As of 2026-03-16, the Relative Valuation of FibroGen Inc (FGEN) is 1,187.43 USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.71 USD, the upside of FibroGen Inc based on Relative Valuation is 12128.9%.
The range of the Relative Valuation is 1,150.15 - 1,224.70 USD.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | 21.6x - 23.0x | 22.3x |
| Fair Price | 1,150.15 - 1,224.70 | 1,187.43 |
| Upside | 11745.1% - 12512.8% | 12128.9% |
| Date | P/E |